New China Life Insurance Company Ltd. (SHA:601336)
China · Delayed Price · Currency is CNY 57.63
-0.78 (-1.34%)
Sep 15, 2026, 3:00 PM CST
SHA:601336 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Premiums & Annuity Revenue | 50,066 | 48,377 | 45,894 | 45,597 | 56,878 | 161,314 |
Total Interest & Dividend Income | -38,327 | -32,042 | -15,890 | 15,089 | 5,237 | 57,288 |
Gain (Loss) on Sale of Investments | 68,289 | 55,313 | 33,600 | -18,925 | 1,468 | -45 |
Other Revenue | 2,996 | 2,996 | 1,495 | 319 | 1,137 | 1,570 |
| 83,024 | 74,644 | 65,099 | 42,080 | 64,720 | 220,127 | |
Revenue Growth | 17.10% | 14.66% | 54.70% | -34.98% | -70.60% | 8.02% |
Policy Benefits | 29,570 | 30,243 | 29,992 | 31,571 | 33,083 | 173,464 |
Policy Acquisition & Underwriting Costs | - | - | - | - | - | 14,592 |
Selling, General & Administrative | 2,773 | 2,773 | 3,062 | 2,370 | - | 12,472 |
Other Operating Expenses | 1,065 | 749 | 712 | 620 | 3,861 | 3,042 |
Total Operating Expenses | 33,408 | 33,765 | 33,766 | 34,561 | 36,944 | 203,570 |
Operating Income | 49,616 | 40,879 | 31,333 | 7,519 | 27,776 | 16,557 |
Interest Expense | -3,024 | -3,510 | -3,166 | -2,086 | -1,173 | -800 |
Earnings From Equity Investments | 1,167 | - | - | - | -18 | - |
Currency Exchange Gain (Loss) | -162 | -162 | 80 | 113 | -4,506 | -116 |
Other Non Operating Income (Expenses) | -71 | -86 | -30 | -2 | - | - |
EBT Excluding Unusual Items | 47,526 | 37,121 | 28,217 | 5,544 | 22,079 | 15,641 |
Gain (Loss) on Sale of Assets | - | - | -3 | -1 | - | -5 |
Asset Writedown | - | - | - | - | - | -3 |
Other Unusual Items | 3,404 | 3,404 | -73 | -28 | - | 37 |
Pretax Income | 50,930 | 40,525 | 28,141 | 5,515 | 22,079 | 15,670 |
Income Tax Expense | 6,646 | 4,236 | 1,908 | -3,201 | 575 | 719 |
Earnings From Continuing Ops. | 44,284 | 36,289 | 26,233 | 8,716 | 21,504 | 14,951 |
Minority Interest in Earnings | -6 | -5 | -4 | -4 | -4 | -4 |
Net Income | 44,278 | 36,284 | 26,229 | 8,712 | 21,500 | 14,947 |
Net Income to Common | 44,278 | 36,284 | 26,229 | 8,712 | 21,500 | 14,947 |
Net Income Growth | 47.86% | 38.34% | 201.07% | -59.48% | 43.84% | 4.57% |
Shares Outstanding (Basic) | 3,120 | 3,120 | 3,120 | 3,120 | 3,120 | 3,120 |
Shares Outstanding (Diluted) | 3,120 | 3,120 | 3,120 | 3,120 | 3,120 | 3,120 |
Shares Change | - | - | - | - | - | - |
EPS (Basic) | 14.19 | 11.63 | 8.41 | 2.79 | 6.89 | 4.79 |
EPS (Diluted) | 14.19 | 11.63 | 8.41 | 2.79 | 6.89 | 4.79 |
EPS Growth | 47.86% | 38.34% | 201.32% | -59.51% | 43.84% | 4.58% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 106,939 | 109,434 | 95,190 | 89,458 | 86,727 | 70,595 |
Free Cash Flow Per Share | 34.27 | 35.08 | 30.51 | 28.67 | 27.80 | 22.63 |
Dividend Per Share | 2.790 | 2.730 | 2.530 | 0.850 | 1.080 | 1.440 |
Dividend Growth | 4.89% | 7.90% | 197.65% | -21.30% | -25.00% | 3.60% |
Operating Margin | 59.76% | 54.77% | 48.13% | 17.87% | 42.92% | 7.52% |
Profit Margin | 53.33% | 48.61% | 40.29% | 20.70% | 33.22% | 6.79% |
Free Cash Flow Margin | 128.80% | 146.61% | 146.22% | 212.59% | 134.00% | 32.07% |
EBITDA | 50,716 | 41,943 | 32,337 | 8,537 | 28,886 | 17,382 |
EBITDA Margin | 61.09% | 56.19% | 49.67% | 20.29% | 44.63% | 7.90% |
D&A For EBITDA | 1,100 | 1,064 | 1,004 | 1,018 | 1,110 | 825 |
EBIT | 49,616 | 40,879 | 31,333 | 7,519 | 27,776 | 16,557 |
EBIT Margin | 59.76% | 54.77% | 48.13% | 17.87% | 42.92% | 7.52% |
Effective Tax Rate | 13.05% | 10.45% | 6.78% | - | 2.60% | 4.59% |
Revenue as Reported | - | - | - | - | 108,164 | 222,380 |